NEKTAR THERAPEUTICS (NKTR)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, NEKTAR THERAPEUTICS reported revenue of $55.23M, down 43.9% from the prior year. The company ran a net loss, with a net margin of -297.1%. It held $280.41M in total assets against $190.57M in total liabilities.
Key ratios (FY2025)
-253.7%
Operating margin
-297.1%
Net margin
-182.6%
Return on equity
-43.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55.23M | $98.43M | $90.12M | $92.06M | $101.91M | $152.91M | $114.62M | $1.19B | $307.71M | $165.44M |
| Cost of Revenue | $0 | $30.69M | $33.77M | $21.64M | $24.90M | $19.48M | $21.37M | $24.41M | $30.55M | $30.21M |
| Operating Income | -$140.10M | -$105.20M | -$263.68M | -$376.17M | -$446.10M | -$425.11M | -$440.04M | $687.93M | -$59.64M | -$112.86M |
| Net Income | -$164.08M | -$118.96M | -$276.06M | -$368.20M | -$523.84M | -$444.44M | -$440.67M | $681.31M | -$96.69M | -$153.52M |
| EPS (Diluted) | $-9.73 | $-8.68 | $-1.45 | $-1.97 | $-2.86 | $-2.49 | $-2.52 | $3.78 | $-0.62 | $-1.10 |
| Total Assets | $280.41M | $303.85M | $398.03M | $710.60M | $1.12B | $1.54B | $1.98B | $2.15B | $508.87M | $568.87M |
| Total Liabilities | $190.57M | $243.11M | $267.05M | $343.96M | $437.68M | $461.47M | $571.97M | $432.60M | $421.04M | $480.75M |
| Shareholders' Equity | $89.83M | $60.74M | $130.99M | $366.64M | $679.51M | $1.08B | $1.41B | $1.72B | $87.83M | $88.12M |
| Cash & Equivalents | $15.12M | $44.25M | $35.28M | $88.23M | $25.22M | $198.96M | $96.36M | $194.91M | $4.76M | $59.64M |
| Operating Cash Flow | -$208.51M | -$175.71M | -$192.61M | -$304.01M | -$412.66M | -$313.29M | -$328.68M | $718.21M | -$80.41M | -$117.02M |
| Capital Expenditures | $171.0K | $1.47M | $865.0K | $5.68M | $14.99M | $7.26M | $26.29M | $14.24M | $9.68M | $6.39M |
| Shares Outstanding | 20.38M | 12.39M | 191.38M | 188.56M | 185.47M | 180.09M | 176.50M | 173.53M | 159.52M | 153.21M |